More clinical and real-world data is needed on how well and for how long Covid-19 vaccines are protective before any decisions should be made on offering third or booster doses, Europe's drug regulators said on Wednesday. Speaking at the first of planned regular fortnightly media briefings on the coronavirus pandemic, the European Medicines Agency's head of biological health